Table 3.
Types and prevalence of PIs (n = 313) in 213 patients.
| Type of PI | No. of PIs (%) |
|---|---|
| Duplication | 87 (27.8%) |
| Co-prescribe same drug class | 45 (14.38%) |
| Co-prescribe same drug | 42 (13.42%) |
| Poor Prescribing Practice | 41 (13.1%) |
| Frequency of administration unclear | 24 (7.67%) |
| Dose charted unclear | 13 (4.15%) |
| Drug charted unclear | 4 (1.28%) |
| Frequency 1 | 38 (12.14%) |
| More than approved normal frequency | 21 (6.71%) |
| Less than approved normal frequency | 17 (5.43%) |
| Dose 1 | 33 (10.54%) |
| More than approved normal dose | 25 (7.99%) |
| Less than approved normal dose | 8 (2.56%) |
| Interaction 1 | 32 (10.22%) |
| Pharmacokinetic | 30 (9.58%) |
| Pharmacodynamic | 2 (0.64%) |
| Timing 1,2 | 27 (8.63%) |
| Review Therapy | 23 (7.35%) |
| Omission 3 | 12 (3.83%) |
| Route | 4 (1.28%) |
| Duration | 3 (0.96%) |
| Other 4 | 13 (4.15%) |
| Total | 313 (100%) |
PI: pharmacist intervention; PIs: pharmacist interventions. 1 As per Summary of Product Characteristics; 2 As per British National Formulary 71 [12]; 3 Relative to admission notes, this intervention was opportunistic; 4 For example, this includes medicines incorrectly transcribed.